Cabergoline – (81409-90-7)

Cabergoline is a dopamine D2 receptor agonist used primarily for the treatment of hyperprolactinemic disorders, including prolactinomas, and Parkinson’s disease. It is an ergot derivative with a long half-life, allowing for less frequent dosing.

Cabergoline works by inhibiting prolactin secretion from the pituitary gland, normalizing prolactin levels, and reducing tumor size in prolactinomas. It is also used off-label for conditions such as restless legs syndrome and as an adjunct in fertility treatments.

The above information is displayed for information purpose only, and has not been reviewed by EON nor does EON attests or validates the accuracy nor does it constitutes a recommendation or validation.

Cabergoline is a dopamine D2 receptor agonist used primarily for the treatment of hyperprolactinemic disorders, including prolactinomas, and Parkinson’s disease. It is an ergot derivative with a long half-life, allowing for less frequent dosing.

Cabergoline works by inhibiting prolactin secretion from the pituitary gland, normalizing prolactin levels, and reducing tumor size in prolactinomas. It is also used off-label for conditions such as restless legs syndrome and as an adjunct in fertility treatments.

The above informationis displayed for information purpose only, and has not been reviewed by EON nor does EON attests or validates the accuracy nor does it constitutes a recommendation or validation.

Sources:

https://en.wikipedia.org/wiki/Cabergoline
https://pubchem.ncbi.nlm.nih.gov/compound/54746
https://www.medchemexpress.com/Cabergoline.html
https://www.medkoo.com/products/11270
https://psychonautwiki.org/wiki/Talk:Cabergoline
https://my.clevelandclinic.org/health/drugs/20863-cabergoline-tablets
https://www.sciencedirect.com/topics/medicine-and-dentistry/cabergoline

Other Names	cabergoline, Dostinex, Cabaser, Cabergolina
IUPAC Name	(6aR, 9R, 10aR)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-7-prop-2-enyl-6, 6a, 8, 9, 10, 10a-hexahydro-4H-indolo[4, 3-fg]quinoline-9-carboxamide
CAS	81409-90-7
Molecular Weight	451.6
Molecular Formula	C26H37N5O2
SMILES	CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)CC=C

Products

Consulting & Services

Check Out Our Research And Updates

Cabergoline – (81409-90-7)

Cabergoline is a dopamine D2 receptor agonist used primarily for the treatment of hyperprolactinemic disorders, including prolactinomas, and Parkinson’s disease. It is an ergot derivative with a long half-life, allowing for less frequent dosing.

Cabergoline works by inhibiting prolactin secretion from the pituitary gland, normalizing prolactin levels, and reducing tumor size in prolactinomas. It is also used off-label for conditions such as restless legs syndrome and as an adjunct in fertility treatments.

The above informationis displayed for information purpose only, and has not been reviewed by EON nor does EON attests or validates the accuracy nor does it constitutes a recommendation or validation.

Sources:

About Us

Products

Services

Quick Contact

Check Out Our Research And Updates

Cabergoline – (81409-90-7)

Cabergoline is a dopamine D2 receptor agonist used primarily for the treatment of hyperprolactinemic disorders, including prolactinomas, and Parkinson’s disease. It is an ergot derivative with a long half-life, allowing for less frequent dosing.

Cabergoline works by inhibiting prolactin secretion from the pituitary gland, normalizing prolactin levels, and reducing tumor size in prolactinomas. It is also used off-label for conditions such as restless legs syndrome and as an adjunct in fertility treatments.

The above informationis displayed for information purpose only, and has not been reviewed by EON nor does EON attests or validates the accuracy nor does it constitutes a recommendation or validation.

Sources:

Related products

Quick Contact